Session 3 of #BacktoHeart21 happening now and covering #Lipids moderated by @FaRodriguezMD @PamelaBMorris & @DLBHATTMD!
First up @alanbrownmd covers COVID-19 and statin therapy! Promising observational data and many RCTs ongoing!
@MedscapeLIVE
@FaRodriguezMD @PamelaBMorris @DLBHATTMD @alanbrownmd @MedscapeLIVE Next up @PamelaBMorris discusses lipid lowering beyond statins!
More data to come for bempedoic acid, Evinacumab, and Inclisiran! Lots of options emerging for LDL lowering
@FaRodriguezMD @PamelaBMorris @DLBHATTMD @alanbrownmd @MedscapeLIVE @DrRSRosenson provides a expert review of HIV and ischemic heart disease!
> HIV patients have high rates of CV events
> Lipid lowering therapy are underutilized
> 1/4 patients are treated with contraindicated statins or doses
@FaRodriguezMD @PamelaBMorris @DLBHATTMD @alanbrownmd @MedscapeLIVE @DrRSRosenson @JSaseenPharmD discussed TG lowering therapy and CV disease!
> EPA only omega 3 products beneficial with significant reduction in CV events demonstrated in the REDUCE-IT trial
> Be mindful of the increased risk of AF
@PamTaubMD discusses primary prevention for high-risk patients
> Dr. Taub makes a strong argument for incorporting more biomarkers beyond LDL to guide risk and management
> More personalized management needed to prevent events!
@DLBHATTMD provides a masterclass overview on antiplatelet and anticoagulant therapy for CVD to wrap up the session!
Dr. Bhatt discusses duration of DAPT & addition of low dose anticoagulation for stable CAD!
#BacktoHeart21
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.